Bioequivalence and Bioavailability Forum 01:44 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Steady State design [Design Issues]

posted by rajasekharkakarla - India, 2018-05-03 12:28  - Posting: # 18753
Views: 677

Dear Sir/Madam,

I have some doubts in designing study state protocols.

Example: Tamsulosin

how to fix number of days to dosing

how to fix number of doses per day

My regular practice is if label/smpc states achievement of steady-state concentrations by the fifth day of once-a-day dosing for Tamsulosin, i will design the study state protocol with once a day dosing for five days. but i want to know the exact scientific rationale behind this.

please help me...

Regards,
Rajasekhar


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,697 posts in 3,982 threads, 1,232 registered users;
online 15 (0 registered, 15 guests [including 11 identified bots]).

I have had my results for a long time:
but I do not yet know how I am to arrive
at them.    Carl Friedrich Gauß

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed